Nucleotides and transported substrates modulate different steps of the ATPase catalytic cycle of MRP1 multidrug transporter

András Kern, Zsófia Szentpétery, K. Liliom, E. Bakos, B. Sarkadi, A. Váradi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The human ABC (ATP-binding cassette) transporter MRP1 (human multidrug-resistance-associated protein 1; ABCC1) is involved in the cellular extrusion of conjugated metabolites and causes multidrug resistance in tumour cells. The transport of substrate molecules by ABC proteins is energized by ATP hydrolysis, performed by two co-operating ABC units. Orthovanadate (Vi), a non-covalent inhibitor of the ABC ATPases, was found to catalyse a photo-oxidative cleavage of various ATP-binding proteins. In the present study, we have identified three Vi-cleavage sites within MRP1, and found that the cleavage reactions were variably modulated by the presence of nucleotides and by transported substrates. We concluded that Vi cleavage of MRP1 at Site I detects conformational changes due to the binding of MgATP. In contrast, Site II could be identified as part of the substrate-modulated catalytic cycle, probably containing an MRP1·MgADP·Vi transition-state-like complex. Cleavage at Site III was modulated by both the binding and hydrolysis of MgATP, in a biphasic pattern, which was also affected by the presence of transported substrates. We detected two different allosteric effects and found that they control two consecutive steps of the MRP1 ATPase catalytic cycle. Nucleotide binding to the low-affinity site accelerated the formation of the pre-hydrolytic intermediate in the other catalytic centre. Interaction of the transporter with its transported substrates stimulated a later reaction of the hydrolytic cycle, the formation of the post-hydrolytic intermediate, which could be detected in both catalytic sites by the experimental strategy used.

Original languageEnglish
Pages (from-to)549-560
Number of pages12
JournalBiochemical Journal
Volume380
Issue number2
DOIs
Publication statusPublished - Jun 1 2004

Fingerprint

Adenosine Triphosphatases
Nucleotides
Adenosine Triphosphate
Substrates
Hydrolysis
Carrier Proteins
ATP-Binding Cassette Transporters
Vanadates
Multiple Drug Resistance
Metabolites
multidrug resistance-associated protein 1
Extrusion
Tumors
Catalytic Domain
Cells
Molecules
Neoplasms
Proteins

Keywords

  • ATP-binding cassette transporter (ABC transporter)
  • ATPase catalytic cycle
  • Multidrug-resistance-associated protein 1 (MRP1)
  • Pre- and post-hydrolytic intermediate
  • Transition state
  • Vanadate cleavage

ASJC Scopus subject areas

  • Biochemistry

Cite this

Nucleotides and transported substrates modulate different steps of the ATPase catalytic cycle of MRP1 multidrug transporter. / Kern, András; Szentpétery, Zsófia; Liliom, K.; Bakos, E.; Sarkadi, B.; Váradi, A.

In: Biochemical Journal, Vol. 380, No. 2, 01.06.2004, p. 549-560.

Research output: Contribution to journalArticle

@article{4d71c3b2ea85407eae8c581cb3405b7c,
title = "Nucleotides and transported substrates modulate different steps of the ATPase catalytic cycle of MRP1 multidrug transporter",
abstract = "The human ABC (ATP-binding cassette) transporter MRP1 (human multidrug-resistance-associated protein 1; ABCC1) is involved in the cellular extrusion of conjugated metabolites and causes multidrug resistance in tumour cells. The transport of substrate molecules by ABC proteins is energized by ATP hydrolysis, performed by two co-operating ABC units. Orthovanadate (Vi), a non-covalent inhibitor of the ABC ATPases, was found to catalyse a photo-oxidative cleavage of various ATP-binding proteins. In the present study, we have identified three Vi-cleavage sites within MRP1, and found that the cleavage reactions were variably modulated by the presence of nucleotides and by transported substrates. We concluded that Vi cleavage of MRP1 at Site I detects conformational changes due to the binding of MgATP. In contrast, Site II could be identified as part of the substrate-modulated catalytic cycle, probably containing an MRP1·MgADP·Vi transition-state-like complex. Cleavage at Site III was modulated by both the binding and hydrolysis of MgATP, in a biphasic pattern, which was also affected by the presence of transported substrates. We detected two different allosteric effects and found that they control two consecutive steps of the MRP1 ATPase catalytic cycle. Nucleotide binding to the low-affinity site accelerated the formation of the pre-hydrolytic intermediate in the other catalytic centre. Interaction of the transporter with its transported substrates stimulated a later reaction of the hydrolytic cycle, the formation of the post-hydrolytic intermediate, which could be detected in both catalytic sites by the experimental strategy used.",
keywords = "ATP-binding cassette transporter (ABC transporter), ATPase catalytic cycle, Multidrug-resistance-associated protein 1 (MRP1), Pre- and post-hydrolytic intermediate, Transition state, Vanadate cleavage",
author = "Andr{\'a}s Kern and Zs{\'o}fia Szentp{\'e}tery and K. Liliom and E. Bakos and B. Sarkadi and A. V{\'a}radi",
year = "2004",
month = "6",
day = "1",
doi = "10.1042/BJ20031607",
language = "English",
volume = "380",
pages = "549--560",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "2",

}

TY - JOUR

T1 - Nucleotides and transported substrates modulate different steps of the ATPase catalytic cycle of MRP1 multidrug transporter

AU - Kern, András

AU - Szentpétery, Zsófia

AU - Liliom, K.

AU - Bakos, E.

AU - Sarkadi, B.

AU - Váradi, A.

PY - 2004/6/1

Y1 - 2004/6/1

N2 - The human ABC (ATP-binding cassette) transporter MRP1 (human multidrug-resistance-associated protein 1; ABCC1) is involved in the cellular extrusion of conjugated metabolites and causes multidrug resistance in tumour cells. The transport of substrate molecules by ABC proteins is energized by ATP hydrolysis, performed by two co-operating ABC units. Orthovanadate (Vi), a non-covalent inhibitor of the ABC ATPases, was found to catalyse a photo-oxidative cleavage of various ATP-binding proteins. In the present study, we have identified three Vi-cleavage sites within MRP1, and found that the cleavage reactions were variably modulated by the presence of nucleotides and by transported substrates. We concluded that Vi cleavage of MRP1 at Site I detects conformational changes due to the binding of MgATP. In contrast, Site II could be identified as part of the substrate-modulated catalytic cycle, probably containing an MRP1·MgADP·Vi transition-state-like complex. Cleavage at Site III was modulated by both the binding and hydrolysis of MgATP, in a biphasic pattern, which was also affected by the presence of transported substrates. We detected two different allosteric effects and found that they control two consecutive steps of the MRP1 ATPase catalytic cycle. Nucleotide binding to the low-affinity site accelerated the formation of the pre-hydrolytic intermediate in the other catalytic centre. Interaction of the transporter with its transported substrates stimulated a later reaction of the hydrolytic cycle, the formation of the post-hydrolytic intermediate, which could be detected in both catalytic sites by the experimental strategy used.

AB - The human ABC (ATP-binding cassette) transporter MRP1 (human multidrug-resistance-associated protein 1; ABCC1) is involved in the cellular extrusion of conjugated metabolites and causes multidrug resistance in tumour cells. The transport of substrate molecules by ABC proteins is energized by ATP hydrolysis, performed by two co-operating ABC units. Orthovanadate (Vi), a non-covalent inhibitor of the ABC ATPases, was found to catalyse a photo-oxidative cleavage of various ATP-binding proteins. In the present study, we have identified three Vi-cleavage sites within MRP1, and found that the cleavage reactions were variably modulated by the presence of nucleotides and by transported substrates. We concluded that Vi cleavage of MRP1 at Site I detects conformational changes due to the binding of MgATP. In contrast, Site II could be identified as part of the substrate-modulated catalytic cycle, probably containing an MRP1·MgADP·Vi transition-state-like complex. Cleavage at Site III was modulated by both the binding and hydrolysis of MgATP, in a biphasic pattern, which was also affected by the presence of transported substrates. We detected two different allosteric effects and found that they control two consecutive steps of the MRP1 ATPase catalytic cycle. Nucleotide binding to the low-affinity site accelerated the formation of the pre-hydrolytic intermediate in the other catalytic centre. Interaction of the transporter with its transported substrates stimulated a later reaction of the hydrolytic cycle, the formation of the post-hydrolytic intermediate, which could be detected in both catalytic sites by the experimental strategy used.

KW - ATP-binding cassette transporter (ABC transporter)

KW - ATPase catalytic cycle

KW - Multidrug-resistance-associated protein 1 (MRP1)

KW - Pre- and post-hydrolytic intermediate

KW - Transition state

KW - Vanadate cleavage

UR - http://www.scopus.com/inward/record.url?scp=2942705747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942705747&partnerID=8YFLogxK

U2 - 10.1042/BJ20031607

DO - 10.1042/BJ20031607

M3 - Article

C2 - 14759224

AN - SCOPUS:2942705747

VL - 380

SP - 549

EP - 560

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 2

ER -